Current drug treatments for vestibular disorders
https://doi.org/10.14412/2074-2711-2012-412
Abstract
There has recently been significant progress in the treatment of different diseases accompanied by dizziness. First and foremost, this is due to the development of highly effective medical positioning maneuvers for benign paroxysmal positional vertigo and to their introduction into practice. At the same time, drug treatments for vertigo are being continued under development. The paper considers the current methods of symptomatic and pathogenetic treatment for different diseases of the vestibular system. It gives data on current medicinal approaches to the treatment of vestibular neuronitis, Mеniеre's disease, migraine-associated vertigo, and central vestibulopathies. Furthermore, prospects for the use of drugs together with vestibular exercises to stimulate central vestibular compensation are discussed.
References
1. <div><p>Agrawal Y., Carey J.P., Della Santina C.C. Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001—2004. Arch Int Med 2009;169(10):938-44</p><p>Sixt E., Landahl S. Postural disturbances in a 75-year-old population: I. Prevalence and functional consequences. Age Ageing 1984;16:393-8.</p><p>Rascol O., Hain T.C., Brefel C. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs 1995;50(5):777—91.</p><p>Venail F., Biboulet R., Mondain M. A protective effect of 5-HT3 antagonist against vestibular deficit? Metoclopramide versus ondansetron at the early stage of vestibular neuritis: A pilot study. Eur Ann Otorhinolaryngol Head Neck Dis 2012;129(2):65—8.</p><p>Мельников О.А., Замерград М.В. Доброкачественное позиционное головокружение. Леч врач 2000;1:15-19.</p><p>Пальчун В.Т., Кунельская Н.Л., Ротермел Е.В. Диагноз и лечение доброкачественного пароксизмального головокружения. Вестн оторинолар 2007;1:4-7.</p><p>Korres S.G., Balatsouras D.G., Papouliakos S. et al. Benign paroxysmal positional vertigo and its management. Med Sci Monit 2007;13:275-82.</p><p>Brandt T., Dieterich M. Vertigo and dizziness: common complains. London: Springer, 2004;208 p.</p><p>Guneri E.A., Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012;146(1):104—8.</p><p>Kulcu D.G., Yanik B., Boynukalin S. Efficacy of a home-based exercise program on benign paroxysmal positional vertigo compared with betahistine. J Otolaryngol Head Neck Surg 2008;37(3):373—9.</p><p>Сагалович Б.М., Пальчун В.Т. Болезнь Меньера. М.: МИА,1999;524 с.</p><p>Gates G.A. Meniere's disease review 2005. J Am Acad Audiol 2006;17:16-26.</p><p>Brandt T. Vertigo. Its Multicensory Syndromes. London: Springer, 2000; 503 p.</p><p>Hain T.C., Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003;17(2):85—100.</p><p>Mira E., Guidetti G., Ghilardi L. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003;260(2):73—7.</p><p>Lezius F., Adrion C., Mansmann U. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere's disease: a case series. Eur Arch Otorhinolaryngol 2011;268(8):1237—40.</p><p>Pirodda A., Brandolini C., Raimondi M.C. Meniere's disease: update of etiopathogenetic theories and proposal of a possible model of explanation. Acta Clin Belg 2010;65(3):170-5.</p><p>Casani A.P., Piaggi P., Cerchiai N. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012;146(3):430—7.</p><p>Pullens B., van Benthem P.P. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011;16(3).CD008234.</p><p>Baloh R.W. Clinical practice. Vestibular neuritis. N Engl J Med 2003;348(11):1027—32.</p><p>Strupp M., Zingler V.C., Arbusow V. et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004;351:354-61.</p><p>Fishman J.M., Burgess C., Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev 2011;11(5).CD008607.</p><p>Hillier S.L., McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2011;16(2).CD005397.</p><p>Парфенов В.А., Абдулина О.В., Замерград М.В. Дифференциальный диагноз, прогноз и лечение острого вестибулярного головокружения. Неврол журн 2007;6:21-5.</p><p>Штульман Д.Р. Головокружение и нарушение равновесия. В кн.: Болезни нервной системы. Под ред. Н.Н. Яхно. М.: Медицина, 2005;125—30.</p><p>Strupp M., Thurtell M.J., Shaikh A.G. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011;258(7):1207—22.</p><p>Thurtell M.J., Leigh R.J. Treatment of nystag mus. Curr Treat Options Neurol 2012;14(1):60—72.</p><p>Celebisoy N., Gökcay F., Sirin H. et al. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 2008;28:72-7.</p><p>Crevits L., Bosman T. Migraine-related vertigo: towards a distinctive entity. Clin Neurol Neurosurg 2005;107:82-7.</p><p>Dieterich M., Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999;246:883-92.</p><p>Eggers S.D. Migraine-related vertigo: diagnosis and treatment. Curr Pain Headache Rep 2007;11:217-26.</p><p>Reploeg M.D., Goebel J.A. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002;23:364-71.</p><p>Neuhauser H., Radtke A., Brevern M. et al. Zolmitriptan for treatment of migrainous vertigo: A pilot randomized placebo-controlled trial. Neurology 2003;60:882-3.</p><p>Bisdorff A.R. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004;2:103-8.</p><p>Gans R.E. Vestibular rehabilitation: protocols and programs. San Diego: Singular Publishing group, 1996;120 p.</p><p>Herdman S.J. (ed.). Vestibular Rehabilitation. 2nd ed. Philadelphia, PA: FA Davis, 2000.</p><p>Curthoys I.S. Vestibular compensation and substitution. Curr Opin Neurol 2000;13:27-30.</p><p>Fernandes C.M., Samuel J. The use of piracetam in vertigo. S Afr Med J 1985;68:806-8.</p><p>Hamann K.F. Special ginkgo extract in cases of vertigo: a systematic review of randomised, doubleblind, placebo controlled clinical examinations. HNO 2007;55:258-63.</p><p>Redon C., Lopez C., Bernard-Demanze L. Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss. J Clin Pharmacol 2011;51(4):538-48.</p><p>Lacour M., Tighilet B. Vestibular compensation in the cat: the role of the histaminergic system. Acta Otolaryngol (Suppl) 2000;544:15-8.</p><p>Tighilet B., Leonard J., Lacour M. Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat. J Vestib Res 1995;5:53-66.</p></div><br />
Review
For citations:
Zamergrad MV. Current drug treatments for vestibular disorders. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(3):92-95. (In Russ.) https://doi.org/10.14412/2074-2711-2012-412
Views:
898
Email this article 